EUVIMEDEUVIMED entdecken
Fall-Kontroll-StudieOpen Access

Altered DNA Methylation Patterns in IFI44L and FOXP3 Genes in Patients with Rheumatoid Arthritis: A Case-Control Study

Delnya Gholami, Zahra Ourang, Mohammad Saatchi, Esmat Rigi Yousefabadi, Emran Esmaeilzadeh, Maassoumeh Akhlaghi, Hoda Kavosi, Hamid Reza Khorram Khorshid

Reports of Biochemistry and Molecular Biology · 2025

DOI: 10.66224/rbmb.14.2.314 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift Reports of Biochemistry and Molecular Biology, 2025. Verfasst von Delnya Gholami und 7 weiteren Autor:innen. Beteiligte Einrichtung: Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Epigenetic modifications, particularly DNA methylation, are implicated in the pathogenesis of rheumatoid arthritis (RA). We assessed the diagnostic utility of FOXP3, TET2, and IFI44L methylation in peripheral blood and examined their associations with inflammatory markers.

Methods

We enrolled 100 patients with RA and 105 healthy controls. Clinical and laboratory data were recorded. DNA methylation at FOXP3, TET2, and IFI44L was quantified using MethyQESD (dual enzymatic digestion followed by real-time PCR). Group differences were analyzed with non-parametric tests; diagnostic performance was evaluated by ROC analysis.

Results

FOXP3 promoter methylation was higher in RA than in controls (P = 0.026), whereas IFI44L methylation was lower in RA (P < 0.0001) and showed strong diagnostic performance (AUC 0.811; P < 0.001). TET2 methylation did not differ between groups. In RA, FOXP3 and TET2 methylation correlated positively with CRP and ESR, while IFI44L methylation correlated negatively with these markers Conclusion: IFI44L methylation levels in peripheral blood may serve as a promising diagnostic biomarker for RA. The associations of FOXP3, TET2, and IFI44L methylation with CRP and ESR suggest potential roles in RA-related inflammation.

Schlagwörter

Stichwörter der Autor:innen

DNA MethylationEpigeneticsRheumatoid Arthritis

Autor:innen und Institutionen

  • Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
  • Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Internal Medicine, Arak University of Medical Sciences, Arak, Iran.
  • Department of Biostatistics and Epidemiology, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
  • Personalized Medicine and Genometabolomics Research Center, Hope Generation Foundation, Tehran, Iran.
  • Fetal Health Research Center, Hope Generation Foundation, Tehran, Iran.

Zitieren

APA

Gholami, D., Ourang, Z., Saatchi, M., Rigi Yousefabadi, E., Esmaeilzadeh, E., Akhlaghi, M., Kavosi, H., & Khorram Khorshid, H. R. (2025). Altered DNA Methylation Patterns in IFI44L and FOXP3 Genes in Patients with Rheumatoid Arthritis: A Case-Control Study. Reports of Biochemistry and Molecular Biology. https://doi.org/10.66224/rbmb.14.2.314

Vancouver

Gholami D, Ourang Z, Saatchi M, Rigi Yousefabadi E, Esmaeilzadeh E, Akhlaghi M, et al. Altered DNA Methylation Patterns in IFI44L and FOXP3 Genes in Patients with Rheumatoid Arthritis: A Case-Control Study. Reports of Biochemistry and Molecular Biology. 2025. doi:10.66224/rbmb.14.2.314

BibTeX
@article{Gholami2025,
  author = {Gholami, Delnya and Ourang, Zahra and Saatchi, Mohammad and Rigi Yousefabadi, Esmat and Esmaeilzadeh, Emran and Akhlaghi, Maassoumeh and Kavosi, Hoda and Khorram Khorshid, Hamid Reza},
  title = {Altered DNA Methylation Patterns in IFI44L and FOXP3 Genes in Patients with Rheumatoid Arthritis: A Case-Control Study},
  journal = {Reports of Biochemistry and Molecular Biology},
  year = {2025},
  doi = {10.66224/rbmb.14.2.314}
}
Kostenlos starten →